4.8 Article

Crystal structure of 2C helicase from enterovirus 71

期刊

SCIENCE ADVANCES
卷 3, 期 4, 页码 -

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.1602573

关键词

-

资金

  1. National Natural Science Foundation of China [81572005]
  2. National Key Research and Development Program of China [2016YFD0500300]

向作者/读者索取更多资源

Enterovirus 71 (EV71) is the major pathogen responsible for outbreaks of hand, foot, and mouth disease. EV71 nonstructural protein 2C participates inmany critical events throughout the virus life cycle; however, its precise role is not fully understood. Lack of a high- resolution structure made it difficult to elucidate 2C activity and prevented inhibitor development. We report the 2.5 A-resolution crystal structure of the soluble part of EV71 2C, containing an adenosine triphosphatase (ATPase) domain, a cysteine-rich zinc finger with an unusual fold, and a carboxyl-terminal helical domain. Unlike other AAA+ ATPases, EV71 2C undergoes a carboxyl terminus-mediated self- oligomerization, which is dependent on a specific interaction between the carboxyl- terminal helix of one monomer and a deep pocket formed between the ATPase and the zinc finger domains of the neighboringmonomer. The carboxyl terminus-mediated selfoligomerization is fundamental to 2C ATPase activity and EV71 replication. Our findings suggest a strategy for inhibition of enterovirus replication by disruption of the self-oligomerization interface of 2C.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

Crystal structure of the NS3-like helicase from Alongshan virus

Xiaopan Gao, Kaixiang Zhu, Justyna Wojdyla, Pu Chen, Bo Qin, Ziheng Li, Meitian Wang, Sheng Cui

Article Chemistry, Multidisciplinary

3D-printed holders for in meso in situ fixed-target serial X-ray crystallography

Chia-Ying Huang, Nathalie Meier, Martin Caffrey, Meitian Wang, Vincent Olieric

JOURNAL OF APPLIED CRYSTALLOGRAPHY (2020)

Article Biochemistry & Molecular Biology

Structural basis of human full-length kindlin-3 homotrimer in an auto-inhibited state

Wenting Bu, Zarina Levitskaya, Zhi Yang Loh, Shengyang Jin, Shibom Basu, Rya Ero, Xinfu Yan, Meitian Wang, So Fong Cam Ngan, Siu Kwan Sze, Suet-Mien Tan, Yong-Gui Gao

PLOS BIOLOGY (2020)

Article Biochemical Research Methods

Making a difference in multi-data-set crystallography: simple and deterministic data-scaling/selection methods

Greta M. Assmann, Meitian Wang, Kay Diederichs

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2020)

Article Pharmacology & Pharmacy

Crystal structure of SARS-CoV-2 papain-like protease

Xiaopan Gao, Bo Qin, Pu Chen, Kaixiang Zhu, Pengjiao Hou, Justyna Aleksandra Wojdyla, Meitian Wang, Sheng Cui

Summary: This study provided structural frameworks for PLpro inhibitor design targeting SARS-CoV-2, showing that existing SARS-CoV PLpro inhibitors have some efficacy against SARS-CoV-2 and explored the inhibition mechanism of GRL0617.

ACTA PHARMACEUTICA SINICA B (2021)

Article Multidisciplinary Sciences

Binding of the SARS-CoV-2 spike protein to glycans

Wei Hao, Bo Ma, Ziheng Li, Xiaoyu Wang, Xiaopan Gao, Yaohao Li, Bo Qin, Shiying Shang, Sheng Cui, Zhongping Tan

Summary: The study found that the spike proteins and subunits of SARS-CoV-2, SARS-CoV, and MERS-CoV can bind to heparan sulfate (HS) in a sulfation-dependent manner, with no binding to sialic acid residues detected. This suggests that HS binding may be a general mechanism for these coronaviruses to attach to host cells.

SCIENCE BULLETIN (2021)

Article Multidisciplinary Sciences

Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions

Xiaopan Gao, Kaixiang Zhu, Bo Qin, Vincent Olieric, Meitian Wang, Sheng Cui

Summary: Orf9b, a unique accessory protein of SARS-CoV-2 and SARS-CoV, interacts with TOM70 to potentially interfere with immunity and suppress interferon responses by inhibiting the Hsp90/TOM70 interaction. The specific mechanisms of these interactions shed light on the pathogenesis of these coronaviruses.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Crystal Structure of Mycobacterium tuberculosis Elongation Factor G1

Xiaopan Gao, Xia Yu, Kaixiang Zhu, Bo Qin, Wei Wang, Pu Han, Justyna Aleksandra Wojdyla, Meitian Wang, Sheng Cui

Summary: Mycobacterium tuberculosis (Mtb) caused approximately 10 million tuberculosis cases and 1.2 million deaths globally in 2019. The crystal structure of Mtb EF-G1 in complex with GDP provides a valuable platform for fragment-based screening and aids in the identification of potential EF-G1 inhibitors for drug discovery.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Biochemical Research Methods

Fast fragment- and compound-screening pipeline at the Swiss Light Source

Jakub W. Kaminski, Laura Vera, Dennis P. Stegmann, Jonatan Vering, Deniz Eris, Kate M. L. Smith, Chia Ying Huang, Nathalie Meier, Julia Steuber, Meitian Wang, Guenter Fritz, Justyna A. Wojdyla, May E. Sharpe

Summary: Fragment-based drug discovery has been proven to be an effective and efficient method for identifying new chemical scaffolds. X-ray crystallography can be used to validate and develop identified fragments, and recent technological advancements have enabled the development of dedicated platforms for FBDD using X-ray crystallography.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Biochemical and structural characterization of hepatitis A virus 2C reveals an unusual ribonuclease activity on single-stranded RNA

Pu Chen, Justyna Aleksandra Wojdyla, Ombretta Colasanti, Zhijian Li, Bo Qin, Meitian Wang, Volker Lohmann, Sheng Cui

Summary: This study identified a previously unfound activity of HAV 2C, which is a ribonuclease activity. The crystal structure of an HAV 2C fragment was determined, and the importance of the PBD-Pocket interaction for 2C functions was demonstrated. Furthermore, it was found that other picornavirus 2Cs also possess ribonuclease activity.

NUCLEIC ACIDS RESEARCH (2022)

Article Multidisciplinary Sciences

Structural basis for Sarbecovirus ORF6 mediated blockage of nucleocytoplasmic transport

Xiaopan Gao, Huabin Tian, Kaixiang Zhu, Qing Li, Wei Hao, Linyue Wang, Bo Qin, Hongyu Deng, Sheng Cui

Summary: This study reveals the molecular basis for the antagonistic function of Sarbecovirus ORF6 and suggests a potential strategy for immunosuppressive drug development using ORF6 CTT-derived peptides.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Structural and biochemical characterization of Schlafen11 N-terminal domain

Pengjiao Hou, Wei Hao, Bo Qin, Mengyun Li, Rong Zhao, Sheng Cui

Summary: Schlafen11 is a well-studied protein that plays important roles in cancer therapy and virus-host interactions. The crystal structure and biochemical characteristics of the N-terminal domain (NTD) of Schlafen11 were determined, revealing its potent RNase activity towards type I and II tRNAs and rRNAs. These findings enhance our understanding of the Schlafen family.

NUCLEIC ACIDS RESEARCH (2023)

Article Multidisciplinary Sciences

Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target

Bo Qin, Ziheng Li, Kaiming Tang, Tongyun Wang, Yubin Xie, Sylvain Aumonier, Meitian Wang, Shuofeng Yuan, Sheng Cui

Summary: This study reveals that SARS-CoV-2 SUD has druggable sites for antiviral development and identifies theaflavin 3,3'-digallate as a potent SUD binder with anti-SARS-CoV-2 activity.

NATURE COMMUNICATIONS (2023)

Article Cell Biology

Targeting papain-like protease for broad-spectrum coronavirus inhibition

Shuofeng Yuan, Xiaopan Gao, Kaiming Tang, Jian-Piao Cai, Menglong Hu, Peng Luo, Lei Wen, Zi-Wei Ye, Cuiting Luo, Jessica Oi-Ling Tsang, Chris Chun-Yiu Chan, Yaoqiang Huang, Jianli Cao, Ronghui Liang, Zhenzhi Qin, Bo Qin, Feifei Yin, Hin Chu, Dong-Yan Jin, Ren Sun, Jasper Fuk-Woo Chan, Sheng Cui, Kwok-Yung Yuen

Summary: The study identifies a noncovalent lead inhibitor, F0213, with broad-spectrum antiviral activity against various coronaviruses, including SARS-CoV-2. The compound provides protection in animal models and exhibits dual therapeutic functionality by inhibiting viral polyprotein cleavage and promoting antiviral immunity. The mode of inhibition differs between SARS2-PLpro and MERS-PLpro. These findings suggest that targeting the papain-like protease domain could be a potential strategy for developing pan-coronaviral therapeutics.

PROTEIN & CELL (2022)

暂无数据